Prefilled Syringes

Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Prefilled Syringes market during the historical period of 2012 – 2016. The study presents a deep-dive assessment of the current growth dynamics, major avenues in the estimation year of 2017, and key prospects over the forecast period 2017 – 2026.

According to this intelligent research report, the global market for prefilled syringes is projected to expand at 9.6% CAGR during the period between 2017 and 2026. Furthermore, keeping the sales aspect under serious consideration, more than 10,200,000 thousand units of prefilled syringes are likely to be sold globally by the end of 2026. This assessment functions as a crucial data source for readers, investors and market participants, with an aim to structure their business depending on the prevailing and forecasted market trends.

This report spotlights the various trends and opportunities expected to impact the overall development of the global prefilled syringes market. It has been observed that increasing demand for efficient drug delivery systems, specifically for injectable drug delivery, the requirement for innovative injectable drug delivery alternatives has risen. With benefits such as enhanced safety and ease considering standalone drug injecting systems like prefilled syringes, their demand is anticipated to rise at a greater pace in the near future.

With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. Given the advantages of standalone drug injecting systems such as prefilled syringes, such as ease in use and enhanced safety, their demand is expected to increase at a high pace in the coming years.

According to Fact.MR analysis on prefilled syringes, the global market for prefilled syringes is anticipated to expand at a meteoric rate during the period of forecast. The global prefilled syringes market is poised to grow at a volume CAGR of 9.1% during the period of assessment, 2017-2026 and the sale of prefilled syringes across the globe is estimated to cross US$ 11 Bn by end of the year of assessment (2026).

Manufacturers are focused on developing enhanced prefilled syringe systems to cater to the growing demand for these injectable drug delivery systems. For instance, Becton Dickinson has developed PosiFlush prefilled syringes with a 4% sodium citrate lock solution that can reduce the number of catheters for hemodialysis by about exchanged per 1000 days by about 59% thus minimizing risks.

Request for Sample Report with Statistical Info @ https://www.factmr.com/connectus/sample?flag=S&rep_id=603